Laddar populära aktier...
Cut to Q2e on lagged price increases and softer demand We cut ’22e-’24e EBITA by 6-5%, on tougher environment Trading at a premium of ~40% ...
Q1 report was above our expectations Organic growth to pick up in H2 We leave our EBITA estimates relatively unchanged Q1 report in brief S...
Sales 6% vs. ABG 5% vs. con Adj. EBITDA 8% vs. ABG 16% vs.
Confident message from CEO Supply chain issues expected to be solved by end of 2021 M&A multiples are expanding, but still at low levels Swe...
Key takes from the Q2’21 report Swedencare’s Q2’21 report was strong, although the company continues to see supply chain issues.
Q2 details Q2'21 report: Net sales SEK 160m (-2% vs ABGSC 163m and -2% vs cons 163m), EBITDA SEK 47m (5% vs ABGSC 45m and 6% vs cons 45m), A...
Q2’21e preview Swedencare will report its Q2’21 results on Thursday, 29 July.
